Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
13F holders, Q2 2024 (June 30)11holders +5
5new positions
0sold out
$2.27avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) in their 13F filings, up 5 from Q1 2024. 5 opened new positions and 0 sold out. The largest holders were Nomura Holdings Inc. ($25.1M), Lord, Abbett & Co. LLC ($14.3M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($6.2M).
- Company
- Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
- CUSIP
- 803607AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $28.4M |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 12,521,101 shares bought and 1,356,000 shares sold, net +11,165,101 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Nomura Holdings Inc. | 0.16% | New | 158,890 | $25.1M |
| Lord, Abbett & Co. LLC | 0.05% | Add +784.9% | 11,079,000 | $14.3M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.02% | No change | 4,850,000 | $6.2M |
| New York State Common Retirement Fund | 0.01% | Reduce -25.8% | 3,899,000 | $5.0M |
| Ofi Invest Asset Management | 0.13% | Reduce -0.1% | 4,000,000 | $4.8M |
| Toronto Dominion Bank | 0.01% | New | 2,506,000 | $3.2M |
| Loomis Sayles & Co. L P | 0.00% | Add +1.5% | 14,665 | $2.3M |
| Bank of New York Mellon Corp | 0.00% | No change | 900,000 | $1.2M |
| Choreo, LLC | 0.00% | New | 15,000 | $19K |
| Stonegate Investment Group, LLC | 0.00% | New | 13,000 | $17K |
| Rothschild Investment LLC | 0.00% | New | 1,000 | $1K |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) the manager owns.